Bengaluru-based direct-to-consumer orthopaedic brand Lumov is currently negotiating to raise approximately ₹33 crore in a new funding round. According to Inc42, the investment will be led by Peak XV Partners through its Surge programme. Existing shareholders are also expected to join the deal. Representatives for both Lumov and Peak XV declined to comment on the matter when contacted by the publication.
The company was established in 2024 by Saumaric Dangwal and Ankit Gupta. Both founders possess extensive experience in private equity. Dangwal previously served as a healthcare and consumer investor at Bain Capital. Gupta held positions at Brookfield Private Equity and Steinberg Asset Management. Lumov creates braces and rehabilitation aids in collaboration with specialists from Manipal Hospitals, Apollo Hospitals, Sakra World Hospital, and AIG Hospitals. These products are engineered specifically for Indian patients and local climate conditions.
Lumov markets knee braces, insoles, and lower-back support belts via its website, Flipkart, and Blinkit. This latest capital push follows a seed round in December 2025, where the startup secured $1.2 million. That earlier funding was led by Incubate Fund Asia. Other participants included QRG Investments and Holdings, Havells family office, IIMA Ventures, SIDBI, and angel investors Ashish Gupta, Saket Narang, and Abhishek Goyal. At the time, the founders stated they would deploy the funds to boost manufacturing capabilities, expand sales operations, and create new products for post-surgical care.
Investors are increasingly targeting the musculoskeletal care sector. In September, Betterhood, a preventive pain care brand, raised ₹11.5 crore in a seed round led by Sauce VC. Earlier in the year, chronic pain clinic chain Nivaan Care secured $7 million in Series A funding from Sorin Investments. Additionally, Stance Health, a provider of physiotherapy and rehabilitation services, raised $1 million in pre-seed funding in April 2025. Lumov intends to use the new capital to expand its footprint in Delhi NCR, Hyderabad, and Mumbai while strengthening clinical partnerships.
